Financial News
Fate Therapeutics (NQ: FATE )
4.325
+0.055
(+1.29%)
Streaming Delayed Price
Updated: 10:55 AM EDT, Jul 22, 2024
Add to My Watchlist
Headline News about Fate Therapeutics
![](https://g.foolcdn.com/editorial/images/783899/pensive-invetor-getty.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/07/16/Charles-Schwab-shutter.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/07/16/Konskie--Poland---January-05--2019-Unite_0.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2024/01/fate1600.png)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.png?width=1200&height=800&fit=crop)
Where Fate Therapeutics Stands With Analysts
April 11, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_2.jpeg?width=1200&height=800&fit=crop)
Cracking The Code: Understanding Analyst Reviews For Fate Therapeutics
February 27, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.jpeg?width=1200&height=800&fit=crop)
Recap: Fate Therapeutics Q4 Earnings
February 26, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2024/02/27/image20.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image.jpeg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
A Preview Of Fate Therapeutics's Earnings
February 23, 2024
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2024/01/fate1600.png)
![](https://cdn.benzinga.com/files/images/story/2024/01/03/image23.jpeg?width=1200&height=800&fit=crop)
Pinstripes, SoFi Technologies And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
January 03, 2024
Via Benzinga
Topics
Stocks
Exposures
US Equities
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Tuesday's After-Market Session
December 12, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.jpeg?width=1200&height=800&fit=crop)
Analyst Ratings for Fate Therapeutics
November 09, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.png?width=1200&height=800&fit=crop)
Recap: Fate Therapeutics Q3 Earnings
November 08, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_4.png?width=1200&height=800&fit=crop)
Analyst Ratings for Fate Therapeutics
September 07, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.png?width=1200&height=800&fit=crop)
The Latest Analyst Ratings for Fate Therapeutics
August 16, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_10164.png?width=1200&height=800&fit=crop)
Where Fate Therapeutics Stands With Analysts
May 05, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Fate Therapeutics: Q1 Earnings Insights
May 03, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Fate Therapeutics Earnings Preview
May 02, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/736660/biotech.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/04/24/image22.jpeg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
15 Analysts Have This to Say About Fate Therapeutics
March 27, 2023
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.